Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jeffrey T L Smith. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jeffrey T L Smith har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| EVP & Chief Medical Officer | 26 708 | |
| US:ALDR / Alder BioPharmaceuticals, Inc. | Managing Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jeffrey T L Smith. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jeffrey T L Smith som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-12 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
S - Sale | −9 310 | 26 708 | −25,85 | 22,67 | −211 090 | 605 564 | |
| 2026-01-12 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
M - Exercise | 17 666 | 36 018 | 96,26 | ||||
| 2026-01-05 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
S - Sale | −10 538 | 18 352 | −36,48 | 25,10 | −264 471 | 460 578 | |
| 2026-01-05 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
M - Exercise | 20 000 | 28 890 | 224,97 | ||||
| 2025-01-06 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
S - Sale | −11 110 | 8 890 | −55,55 | 14,92 | −165 807 | 132 675 | |
| 2025-01-06 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
M - Exercise | 20 000 | 20 000 | |||||
| 2024-01-05 | 3 | ZYME |
Zymeworks Inc.
No securities are beneficially owned |
0 | ||||||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −100 000 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −100 000 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −60 000 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −50 000 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −50 000 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −85 000 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −35 000 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −13 636 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −13 636 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −31 818 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −17 271 | 0 | −100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −21 502 | 0 | −100,00 | 18,00 | −387 036 | ||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
A - Award | 16 230 | 21 502 | 307,85 | ||||
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −10 001 | 17 271 | −36,67 | ||||
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −22 727 | 0 | −100,00 | ||||
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −32 728 | 5 272 | −86,13 | 18,44 | −603 504 | 97 216 |
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 001 | 38 000 | 35,72 | 3,46 | 34 653 | 131 670 |
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 22 727 | 27 999 | 431,09 | 4,46 | 101 249 | 124 736 |
| 2019-04-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | X | −4 847 | 5 272 | −47,90 | 13,73 | −66 526 | 72 359 |
| 2019-04-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
A - Award | 9 288 | 10 119 | 1 117,69 | ||||
| 2019-02-08 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
| 2018-12-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 044 | 0 | −100,00 | ||||
| 2018-12-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 044 | 831 | −85,86 | 13,84 | −69 826 | 11 504 |
| 2018-12-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 044 | 5 875 | 606,98 | 0,99 | 4 994 | 5 816 |
| 2018-11-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 040 | 5 044 | −49,98 | ||||
| 2018-11-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 040 | 831 | −85,85 | 13,42 | −67 637 | 11 152 |
| 2018-11-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 040 | 10 084 | −33,32 | ||||
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 831 | −70,65 | 15,97 | −31 944 | 13 273 |
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 040 | 2 831 | −51,78 | 15,26 | −46 385 | 43 196 |
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 040 | 15 124 | −25,00 | ||||
| 2018-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 040 | 831 | −85,85 | 18,00 | −90 699 | 14 955 |
| 2018-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 040 | 20 164 | −20,00 | ||||
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −980 | 831 | −54,11 | 19,76 | −19 369 | 16 424 |
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 060 | 1 811 | −69,15 | 19,49 | −79 120 | 35 292 |
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 040 | 25 204 | −16,66 | ||||
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 121 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 161 | 831 | −93,60 | 15,49 | −188 364 | 12 872 |
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 12 992 | 63,38 | 0,99 | 4 990 | 12 862 |
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 121 | 7 952 | 856,92 | 1,65 | 11 750 | 13 121 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 040 | 30 244 | −14,28 | ||||
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 121 | 7 121 | −50,00 | ||||
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 831 | −56,97 | 18,29 | −20 115 | 15 196 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 061 | 1 931 | −85,14 | 17,81 | −197 012 | 34 394 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 12 992 | 63,38 | 0,99 | 4 990 | 12 862 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 121 | 7 952 | 856,92 | 1,65 | 11 750 | 13 121 |
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 121 | 14 242 | −33,33 | ||||
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −5 040 | 35 284 | −12,50 | ||||
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 161 | 831 | −93,60 | 15,03 | −182 758 | 12 488 |
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 121 | 12 992 | 121,29 | 1,65 | 11 750 | 21 437 |
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-02-21 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 60 000 | 60 000 | |||||
| 2017-12-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
The shares subject to this option shall vest and become exer |
A - Award | 50 000 | 50 000 | |||||
| 2017-06-22 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −585 | 40 324 | −1,43 | ||||
| 2017-06-22 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −585 | 831 | −41,31 | 20,00 | −11 700 | 16 620 |
| 2017-06-22 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 585 | 1 416 | 70,40 | 0,99 | 579 | 1 402 |
| 2017-01-31 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 85 000 | 85 000 | |||||
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 000 | 21 363 | −12,31 | ||||
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 831 | −37,57 | 23,62 | −11 810 | 19 628 |
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 1 331 | −65,26 | 22,61 | −56 518 | 30 090 |
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 831 | 361,01 | 1,65 | 4 950 | 6 321 |
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 000 | 24 363 | −10,96 | ||||
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 0 | −100,00 | 24,88 | −9 950 | |
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 600 | 400 | −86,67 | 24,26 | −63 082 | 9 705 |
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 000 | 27 363 | −9,88 | ||||
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −702 | 0 | −100,00 | 31,62 | −22 199 | |
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 298 | 702 | −76,60 | 30,99 | −71 216 | 21 755 |
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 000 | 30 363 | −8,99 | ||||
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 33,10 | −3 310 | |
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 900 | 100 | −96,67 | 32,47 | −94 173 | 3 247 |
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-08-17 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 000 | 33 363 | −8,25 | ||||
| 2016-08-17 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −3 000 | 0 | −100,00 | 31,17 | −93 512 | ||
| 2016-08-17 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −16 090 | 0 | −100,00 | ||||
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −1 000 | 0 | −100,00 | 31,83 | −31 827 | ||
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −3 805 | 1 000 | −79,19 | 31,00 | −117 940 | 30 996 | |
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −11 285 | 4 805 | −70,14 | 29,79 | −336 167 | 143 135 | |
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 090 | 16 090 | 1,26 | 20 354 | 20 354 | ||
| 2016-02-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
| 2015-12-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −4 272 | 0 | −100,00 | ||||
| 2015-12-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 272 | 0 | −100,00 | 37,24 | −159 104 | |
| 2015-12-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 272 | 4 272 | 0,38 | 1 645 | 1 645 | |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 4 272 | −47,72 | ||||
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 400 | 0 | −100,00 | 34,57 | −48 393 | |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 1 400 | −41,67 | 33,85 | −33 852 | 47 393 |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 2 400 | −38,46 | 32,70 | −49 054 | 78 486 |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 8 172 | −32,31 | ||||
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 32,83 | −3 283 | |
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 800 | 100 | −97,44 | 32,24 | −122 495 | 3 224 |
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 12 072 | −24,42 | ||||
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 500 | 0 | −100,00 | 38,83 | −58 241 | |
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 400 | 1 500 | −61,54 | 38,30 | −91 924 | 57 453 |
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-08-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 15 972 | −19,63 | ||||
| 2015-08-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 900 | 0 | −100,00 | 45,64 | −178 003 | |
| 2015-08-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-07-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 19 872 | −16,41 | ||||
| 2015-07-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 900 | 0 | −100,00 | 51,18 | −199 616 | |
| 2015-07-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-06-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 23 772 | −14,09 | ||||
| 2015-06-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 900 | 0 | −100,00 | 41,53 | −161 969 | |
| 2015-06-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −7 202 | 0 | −100,00 | ||||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −7 202 | 0 | −100,00 | 38,47 | −277 027 | ||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 202 | 7 202 | 0,06 | 396 | 396 | ||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −54 616 | 7 202 | −88,35 | ||||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −54 616 | 0 | −100,00 | 38,92 | −2 125 496 | ||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 54 616 | 54 616 | 0,06 | 3 004 | 3 004 | ||
| 2015-05-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 27 672 | −12,35 | ||||
| 2015-05-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 900 | 0 | −100,00 | 25,67 | −100 130 | |
| 2015-05-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-04-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 31 572 | −10,99 | ||||
| 2015-04-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 900 | 0 | −100,00 | 27,43 | −106 995 | |
| 2015-04-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-03-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −3 900 | 35 472 | −9,91 | ||||
| 2015-03-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 900 | 0 | −100,00 | 26,25 | −102 357 | |
| 2015-03-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −1 200 | 39 372 | −2,96 | ||||
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 0 | −100,00 | 28,27 | −33 921 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 200 | 1 200 | 0,38 | 462 | 462 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −2 700 | 40 572 | −6,24 | ||||
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 50 000 | 50 000 | |||||
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 700 | 0 | −100,00 | 27,89 | −75 316 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 700 | 2 700 | 0,38 | 1 040 | 1 040 | |
| 2014-11-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −9 090 | 0 | −100,00 | 16,91 | −153 735 | ||
| 2014-11-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | −20 000 | 9 090 | −68,75 | 15,71 | −314 118 | 142 767 | |
| 2014-07-10 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 35 000 | 35 000 | |||||
| 2014-05-09 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 13 636 | 13 636 | |||||
| 2014-05-07 | 3 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
58 180 | ||||||||
| 2014-05-07 | 3 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
58 180 |